Eagle Strategies’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$340K Sell
14,052
-594
-4% -$14.4K 0.03% 223
2026
Q1
$355K Buy
14,646
+73
+0.5% +$1.77K 0.04% 207
2025
Q4
$354K Buy
14,573
+149
+1% +$3.62K 0.05% 201
2025
Q3
$351K Buy
14,424
+1,345
+10% +$32.6K 0.05% 192
2025
Q2
$317K Buy
13,079
+97
+0.7% +$2.34K 0.05% 187
2025
Q1
$314K Buy
12,982
+4,293
+49% +$103K 0.05% 173
2024
Q4
$208K Buy
+8,689
New +$209K 0.04% 211

Other funds holding IBDS

Eagle Strategies's IBDS Position: Q2 2026 in Review

Eagle Strategies reduced its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 4.1% in Q2 2026, selling an estimated $14.4K and leaving 14,052 shares worth $340K. The position accounts for 0.03% of the portfolio, ranked #223.

Eagle Strategies first reported a position in IBDS in Q4 2024 and has held it in 7 quarters since. The position peaked at $355K in Q1 2026. 223 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.

  • Eagle Strategies held 14,052 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $340K as of Q2 2026.
  • Eagle Strategies sold 594 iShares iBonds Dec 2027 Term Corporate ETF shares in Q2 2026, an estimated $14.4K.
  • iShares iBonds Dec 2027 Term Corporate ETF made up 0.03% of Eagle Strategies's portfolio in Q2 2026, its #223 holding.
  • Eagle Strategies first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q4 2024 and has held it in 7 quarters since.
  • Eagle Strategies's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $355K in Q1 2026.
  • 223 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.

Based on Eagle Strategies's 13F filing for Q2 2026, filed 21 Jul 2026.